Zacks Research Upgrades Option Care Health (NASDAQ:OPCH) to “Hold”

Option Care Health (NASDAQ:OPCH) was upgraded by analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report issued on Monday,Zacks.com reports.

A number of other research firms have also weighed in on OPCH. Bank of America lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 price target on the stock. in a research report on Friday, May 1st. TD Cowen decreased their target price on shares of Option Care Health from $37.00 to $23.00 and set a “hold” rating on the stock in a research note on Friday, May 1st. JPMorgan Chase & Co. lowered their target price on Option Care Health from $40.00 to $33.00 and set an “overweight” rating on the stock in a report on Monday, May 4th. Truist Financial set a $30.00 price target on Option Care Health in a research report on Friday, May 1st. Finally, Stephens set a $30.00 price target on Option Care Health in a report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and a consensus target price of $30.54.

Option Care Health Stock Up 1.0%

Shares of OPCH opened at $21.57 on Monday. The stock has a 50 day moving average price of $21.39 and a 200 day moving average price of $28.06. Option Care Health has a one year low of $18.01 and a one year high of $36.80. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.07 and a current ratio of 1.64. The stock has a market capitalization of $3.39 billion, a price-to-earnings ratio of 16.72, a PEG ratio of 1.19 and a beta of 0.65.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.03. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. During the same quarter last year, the firm posted $0.40 EPS. The firm’s revenue for the quarter was up 1.3% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Equities research analysts forecast that Option Care Health will post 1.64 earnings per share for the current fiscal year.

Insider Buying and Selling at Option Care Health

In other news, Director Timothy P. Sullivan purchased 24,154 shares of the company’s stock in a transaction dated Thursday, May 7th. The stock was acquired at an average price of $20.69 per share, with a total value of $499,746.26. Following the purchase, the director directly owned 73,383 shares in the company, valued at approximately $1,518,294.27. This represents a 49.06% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO John Charles Rademacher purchased 12,500 shares of the business’s stock in a transaction dated Monday, May 4th. The shares were purchased at an average price of $21.18 per share, with a total value of $264,750.00. Following the acquisition, the chief executive officer directly owned 695,152 shares in the company, valued at approximately $14,723,319.36. The trade was a 1.83% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have bought 73,264 shares of company stock worth $1,548,316 in the last ninety days. 1.70% of the stock is owned by insiders.

Institutional Investors Weigh In On Option Care Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OPCH. Durable Capital Partners LP grew its holdings in shares of Option Care Health by 134.2% during the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after purchasing an additional 4,720,988 shares during the period. Fuller & Thaler Asset Management Inc. raised its holdings in Option Care Health by 12.1% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 6,958,800 shares of the company’s stock valued at $221,707,000 after buying an additional 752,058 shares during the period. Arrowstreet Capital Limited Partnership raised its holdings in Option Care Health by 6.2% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 4,248,425 shares of the company’s stock valued at $135,355,000 after buying an additional 247,118 shares during the period. Dimensional Fund Advisors LP lifted its position in Option Care Health by 0.9% in the first quarter. Dimensional Fund Advisors LP now owns 3,876,856 shares of the company’s stock valued at $104,368,000 after buying an additional 36,208 shares during the last quarter. Finally, Southpoint Capital Advisors LP lifted its position in Option Care Health by 20.0% in the first quarter. Southpoint Capital Advisors LP now owns 3,600,000 shares of the company’s stock valued at $96,912,000 after buying an additional 600,000 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.